08045804946
Send Inquiry
PEMETERO 500MG INJ
1900.0 INR/Number
Product Details:
- Packaging Type Glass vial
- Origin of Medicine India
- Salt Composition Pemetrexed Disodium
- Pacakaging (Quantity Per Box) 1 vial per box
- Brand Name PEMETERO
- Dosage Form Lyophilized powder for injection
- Indication Malignant pleural mesothelioma; Non-small cell lung cancer
- Click to View more
X
PEMETERO 500MG INJ Price And Quantity
- 1900.0 INR/Number
- 1 Number
- 500 mg/vial
- Prescription required
- To be reconstituted with sterile water before administration
- Anticancer / Oncology
- Antimetabolite
- Intravenous
PEMETERO 500MG INJ Product Specifications
- Injection
- Pemetrexed Disodium
- Administered intravenously under medical supervision
- 500 mg per vial
- Adults with malignant pleural mesothelioma or non-small cell lung cancer
- Glass vial
- India
- Lyophilized powder for injection
- PEMETERO
- Malignant pleural mesothelioma; Non-small cell lung cancer
- Prescription medicine
- Check expiry date on pack
- Pemetrexed Disodium
- As prescribed by a healthcare professional
- 1 vial per box
- Store below 25C, protect from light
- Adults
- 500 mg/vial
- Prescription required
- To be reconstituted with sterile water before administration
- Anticancer / Oncology
- Antimetabolite
- Intravenous
PEMETERO 500MG INJ Trade Information
- Cash on Delivery (COD), Cash Advance (CA), Cash in Advance (CID)
- 1000 Number Per Week
- 2 Days
- No
- Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
- All India
Product Description
- Active Ingredient: Pemetrexed 500 mg.
- Mechanism of Action: Pemetrexed works by blocking the action of certain substances (folate-dependent enzymes) that cancer cells need to multiply and grow. This interference stops the growth and spread of cancer cells.
- Medical Uses: It is primarily used to manage advanced stages of:
- Non-small cell lung cancer (NSCLC): A common type of lung cancer. It can be used alone or in combination with other chemotherapy drugs like cisplatin.
- Malignant pleural mesothelioma: A type of cancer that affects the protective layer surrounding the lungs and the inner side of the ribs.
- Administration: The medicine is administered as an intravenous infusion by a qualified healthcare professional in a clinical setting. It is not for self-administration.
- Premedication: To reduce the severity of side effects, doctors may prescribe corticosteroids, folic acid, and vitamin B12 supplements during the treatment.
- Monitoring: Regular blood tests are necessary before each treatment to check kidney and liver function, as well as blood cell counts.
Potential Side Effects
Common side effects often associated with Pemetero include:
- Nausea and vomiting
- Loss of appetite
- Fatigue
- Hair loss (usually temporary)
- Sore throat or mouth inflammation (stomatitis)
- Low blood cell counts (leading to increased risk of infection)
Targeted Cancer Therapy for Adults
PEMETERO 500MG INJ is specifically indicated for the treatment of adults diagnosed with malignant pleural mesothelioma or non-small cell lung cancer. Its potent antimetabolite action interrupts the proliferation of cancer cells, thereby improving treatment outcomes when administered as prescribed by oncology specialists.
Preparation and Administration Guidelines
This medication is supplied as a lyophilized powder and must be reconstituted using sterile water for injection by qualified healthcare professionals. Intravenous administration ensures rapid delivery to the bloodstream, making it ideal for systemic cancer therapy within a clinical or hospital setting.
Safe Handling and Storage
PEMETERO should be stored at temperatures below 25C and away from light until reconstitution. Handling and preparation should be performed by medical staff to maintain product integrity and ensure patient safety, with strict adherence to expiry dates.
FAQ's of PEMETERO 500MG INJ:
Q: How should PEMETERO 500MG INJ be administered?
A: PEMETERO 500MG INJ must be reconstituted with sterile water and administered intravenously by a qualified healthcare professional, typically in a hospital or clinical environment.Q: What conditions is PEMETERO 500MG INJ recommended for?
A: This injection is indicated for adults with malignant pleural mesothelioma or non-small cell lung cancer, as prescribed by an oncologist.Q: When is PEMETERO 500MG INJ used during cancer treatment?
A: PEMETERO is used as part of a chemotherapy regimen, with dosing intervals and cycles specified by your healthcare provider based on your individual cancer diagnosis and treatment plan.Q: Where should PEMETERO 500MG INJ be stored before use?
A: Store PEMETERO below 25C and protect it from light. Always check the expiry date on the packaging before reconstitution and use.Q: What is the process for preparing PEMETERO 500MG INJ for administration?
A: A healthcare professional will reconstitute the lyophilized powder in the vial with sterile water for injection, ensuring proper mixing before delivering it intravenously.Q: Is PEMETERO 500MG INJ suitable for self-administration at home?
A: No, the injection must be administered by trained medical personnel within a clinical setting to ensure safety and effectiveness.Q: What are the core benefits of using PEMETERO 500MG INJ in cancer treatment?
A: PEMETERO's antimetabolite action directly targets cancer cell growth, contributing to the overall effectiveness of chemotherapy protocols for specific lung cancers and mesothelioma.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMSMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
